4
Changes in Ownership
Aclaris Therapeutics, Inc. Filed Acc 0001209191-23-008451
Chief Business Officer sold 4,267 shares at $13.89 ($59,272)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Loerop James Chief Business Officer | 2023-02-08 | Sale | −4,267 | $13.89 | $59,272 | 6,983 | D |
| Open-market sales · 4,267 sh · avg $13.89 · $59,272 | |||||||
Loading xslF345X03/doc4.xml…